Clinical Data Obtains Viibryd Approval In U.S.
Massachusetts-based biotech Clinical Data has gotten approval from FDA to bring its first product to market, an antidepressant called Viibryd that it in-licensed from Merck KGaA.
Massachusetts-based biotech Clinical Data has gotten approval from FDA to bring its first product to market, an antidepressant called Viibryd that it in-licensed from Merck KGaA.